These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 32792905)

  • 1. The Redox Biology of Excitotoxic Processes: The NMDA Receptor, TOPA Quinone, and the Oxidative Liberation of Intracellular Zinc.
    Aizenman E; Loring RH; Reynolds IJ; Rosenberg PA
    Front Neurosci; 2020; 14():778. PubMed ID: 32792905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonenzymatic conversion of 3,4-dihydroxyphenylalanine to 2,4,5-trihydroxyphenylalanine and 2,4,5-trihydroxyphenylalanine quinone in physiological solutions.
    Newcomer TA; Palmer AM; Rosenberg PA; Aizenman E
    J Neurochem; 1993 Sep; 61(3):911-20. PubMed ID: 8360690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutathione prevents 2,4,5-trihydroxyphenylalanine excitotoxicity by maintaining it in a reduced, non-active form.
    Aizenman E; Boeckman FA; Rosenberg PA
    Neurosci Lett; 1992 Sep; 144(1-2):233-6. PubMed ID: 1436708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanisms of calcium-dependent neurodegeneration in excitotoxicity.
    Arundine M; Tymianski M
    Cell Calcium; 2003; 34(4-5):325-37. PubMed ID: 12909079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of 2,4,5-trihydroxyphenylalanine neurotoxicity in vitro and protective effects of ganglioside GM1: implications for Parkinson's disease.
    Skaper SD; Facci L; Schiavo N; Vantini G; Moroni F; Dal Toso R; Leon A
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1440-6. PubMed ID: 1361575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TOPA quinone, a kainate-like agonist and excitotoxin is generated by a catecholaminergic cell line.
    Newcomer TA; Rosenberg PA; Aizenman E
    J Neurosci; 1995 Apr; 15(4):3172-7. PubMed ID: 7722654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory mediators leading to protein misfolding and uncompetitive/fast off-rate drug therapy for neurodegenerative disorders.
    Lipton SA; Gu Z; Nakamura T
    Int Rev Neurobiol; 2007; 82():1-27. PubMed ID: 17678953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2,4,5-trihydroxyphenylalanine in solution forms a non-N-methyl-D-aspartate glutamatergic agonist and neurotoxin.
    Rosenberg PA; Loring R; Xie Y; Zaleskas V; Aizenman E
    Proc Natl Acad Sci U S A; 1991 Jun; 88(11):4865-9. PubMed ID: 1675790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NMDA receptor modulation by the neuropeptide apelin: implications for excitotoxic injury.
    Cook DR; Gleichman AJ; Cross SA; Doshi S; Ho W; Jordan-Sciutto KL; Lynch DR; Kolson DL
    J Neurochem; 2011 Sep; 118(6):1113-23. PubMed ID: 21749375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular survival pathways against glutamate receptor agonist excitotoxicity in cultured neurons. Intracellular calcium responses.
    Marini AM; Ueda Y; June CH
    Ann N Y Acad Sci; 1999; 890():421-37. PubMed ID: 10668447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of mGluR5 attenuates NMDA-induced neurotoxicity through disruption of the NMDAR-PSD-95 complex and preservation of mitochondrial function in differentiated PC12 cells.
    Dai SH; Qin N; Chen T; Luo P; Zhang L; Rao W; Yang YF; Jiang XF; Fei Z
    Int J Mol Sci; 2014 Jun; 15(6):10892-907. PubMed ID: 24941251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 3,4-dihydroxyphenylalanine oxidation product is a non-N-methyl-D-aspartate glutamatergic agonist in rat cortical neurons.
    Aizenman E; White WF; Loring RH; Rosenberg PA
    Neurosci Lett; 1990 Aug; 116(1-2):168-71. PubMed ID: 1979663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Slack K
    Ehinger R; Kuret A; Matt L; Frank N; Wild K; Kabagema-Bilan C; Bischof H; Malli R; Ruth P; Bausch AE; Lukowski R
    FASEB J; 2021 May; 35(5):e21568. PubMed ID: 33817875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glutamate-mediated excitotoxic death of cultured striatal neurons is mediated by non-NMDA receptors.
    Chen Q; Harris C; Brown CS; Howe A; Surmeier DJ; Reiner A
    Exp Neurol; 1995 Dec; 136(2):212-24. PubMed ID: 7498411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paradigm shift in NMDA receptor antagonist drug development: molecular mechanism of uncompetitive inhibition by memantine in the treatment of Alzheimer's disease and other neurologic disorders.
    Lipton SA
    J Alzheimers Dis; 2004 Dec; 6(6 Suppl):S61-74. PubMed ID: 15665416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iron-mediated oxidation of 3,4-dihydroxyphenylalanine to an excitotoxin.
    Newcomer TA; Rosenberg PA; Aizenman E
    J Neurochem; 1995 Apr; 64(4):1742-8. PubMed ID: 7891103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathologically-activated therapeutics for neuroprotection: mechanism of NMDA receptor block by memantine and S-nitrosylation.
    Lipton SA
    Curr Drug Targets; 2007 May; 8(5):621-32. PubMed ID: 17504105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of caspase-6 and cleavage of caspase-6 substrates is an early event in NMDA receptor-mediated excitotoxicity.
    Girling KD; Demers MJ; Laine J; Zhang S; Wang YT; Graham RK
    J Neurosci Res; 2018 Mar; 96(3):391-406. PubMed ID: 29193273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2,4,5-Trihydroxyphenylalanine (6-hydroxy-dopa) displaces [3H]AMPA binding in rat striatum.
    Cha JH; Dure LS IV; Sakurai SY; Penney JB; Young AB
    Neurosci Lett; 1991 Oct; 132(1):55-8. PubMed ID: 1664920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurodegeneration in excitotoxicity, global cerebral ischemia, and target deprivation: A perspective on the contributions of apoptosis and necrosis.
    Martin LJ; Al-Abdulla NA; Brambrink AM; Kirsch JR; Sieber FE; Portera-Cailliau C
    Brain Res Bull; 1998 Jul; 46(4):281-309. PubMed ID: 9671259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.